• Something wrong with this record ?

Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy

F. Claps, MC. Mir, BWG. van Rhijn, G. Mazzon, F. Soria, D. D'Andrea, G. Marra, M. Boltri, F. Traunero, M. Massanova, G. Liguori, JL. Dominguez-Escrig, A. Celia, P. Gontero, SF. Shariat, C. Trombetta, N. Pavan

. 2023 ; 41 (1) : 49.e13-49.e22. [pub] 20221021

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22032048

INTRODUCTION AND OBJECTIVES: To evaluate the impact of the Controlling Nutritional Status (CONUT) score on perioperative morbidity and oncological outcomes of bladder cancer (BC) patients treated with radical cystectomy (RC). MATERIALS AND METHODS: We retrospectively analyzed a multi-institutional cohort of 347 patients treated with RC for clinical-localized BC between 2005 and 2019. The CONUT-score was defined as an algorithm including serum albumin, total lymphocyte count, and cholesterol. Multivariable logistic regression analyses were performed to evaluate the ability of the CONUT-score to predict any-grade complications, major complications and 30 days readmission. Multivariable Cox' regression models were performed to evaluate the prognostic effect of the CONUT-score on recurrence-free survival (RFS), overall survival (OS), and cancer-specific survival (CSS). RESULTS: A cut-off value to discriminate between low and high CONUT-score was determined by calculating the receiver operating characteristic (ROC) curve. The area under the curve was 0.72 hence high CONUT-score was defined as ≥3 points. Overall, 112 (32.3%) patients had a high CONUT. At multivariable logistic regression analyses, high CONUT was associated with any-grade complications (OR 3.58, P = 0.001), major complications (OR 2.56, P = 0.003) and 30 days readmission (OR 2.39, P = 0.01). On multivariable Cox' regression analyses, high CONUT remained associated with worse RFS (HR 2.57, P < 0.001), OS (HR 2.37, P < 0.001) and CSS (HR 3.52, P < 0.001). CONCLUSIONS: Poor nutritional status measured by the CONUT-score is independently associated with a poorer postoperative course after RC and is predictive of worse RFS, OS, and CSS. This simple index could serve as a comprehensive personalized risk-stratification tool identifying patients who may benefit from an intensified regimen of supportive cares.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22032048
003      
CZ-PrNML
005      
20230131151458.0
007      
ta
008      
230120s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.urolonc.2022.09.023 $2 doi
035    __
$a (PubMed)36274030
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Claps, Francesco $u Urological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy; Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain. Electronic address: claps.francesco@gmail.com
245    10
$a Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy / $c F. Claps, MC. Mir, BWG. van Rhijn, G. Mazzon, F. Soria, D. D'Andrea, G. Marra, M. Boltri, F. Traunero, M. Massanova, G. Liguori, JL. Dominguez-Escrig, A. Celia, P. Gontero, SF. Shariat, C. Trombetta, N. Pavan
520    9_
$a INTRODUCTION AND OBJECTIVES: To evaluate the impact of the Controlling Nutritional Status (CONUT) score on perioperative morbidity and oncological outcomes of bladder cancer (BC) patients treated with radical cystectomy (RC). MATERIALS AND METHODS: We retrospectively analyzed a multi-institutional cohort of 347 patients treated with RC for clinical-localized BC between 2005 and 2019. The CONUT-score was defined as an algorithm including serum albumin, total lymphocyte count, and cholesterol. Multivariable logistic regression analyses were performed to evaluate the ability of the CONUT-score to predict any-grade complications, major complications and 30 days readmission. Multivariable Cox' regression models were performed to evaluate the prognostic effect of the CONUT-score on recurrence-free survival (RFS), overall survival (OS), and cancer-specific survival (CSS). RESULTS: A cut-off value to discriminate between low and high CONUT-score was determined by calculating the receiver operating characteristic (ROC) curve. The area under the curve was 0.72 hence high CONUT-score was defined as ≥3 points. Overall, 112 (32.3%) patients had a high CONUT. At multivariable logistic regression analyses, high CONUT was associated with any-grade complications (OR 3.58, P = 0.001), major complications (OR 2.56, P = 0.003) and 30 days readmission (OR 2.39, P = 0.01). On multivariable Cox' regression analyses, high CONUT remained associated with worse RFS (HR 2.57, P < 0.001), OS (HR 2.37, P < 0.001) and CSS (HR 3.52, P < 0.001). CONCLUSIONS: Poor nutritional status measured by the CONUT-score is independently associated with a poorer postoperative course after RC and is predictive of worse RFS, OS, and CSS. This simple index could serve as a comprehensive personalized risk-stratification tool identifying patients who may benefit from an intensified regimen of supportive cares.
650    _2
$a lidé $7 D006801
650    12
$a cystektomie $7 D015653
650    12
$a nádory močového měchýře $x chirurgie $7 D001749
650    _2
$a nutriční stav $7 D009752
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a prognóza $7 D011379
650    _2
$a morbidita $7 D009017
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mir, Maria Carmen $u Department of Urology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain
700    1_
$a van Rhijn, Bas W G $u Department of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
700    1_
$a Mazzon, Giorgio $u Department of Urology, San Bassiano Hospital, Bassano del Grappa, Italy
700    1_
$a Soria, Francesco $u Department of Urology, Medical University of Vienna, Vienna, Austria; Division of Urology, Department of Surgical Sciences, University of Torino School of Medicine, Turin, Italy
700    1_
$a D'Andrea, David $u Department of Urology, Medical University of Vienna, Vienna, Austria
700    1_
$a Marra, Giancarlo $u Division of Urology, Department of Surgical Sciences, University of Torino School of Medicine, Turin, Italy
700    1_
$a Boltri, Matteo $u Urological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy
700    1_
$a Traunero, Fabio $u Urological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy
700    1_
$a Massanova, Matteo $u Department of Urology, San Bassiano Hospital, Bassano del Grappa, Italy
700    1_
$a Liguori, Giovanni $u Urological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy
700    1_
$a Dominguez-Escrig, Jose L $u Department of Urology, Fundacion Instituto Valenciano de Oncologia, Valencia, Spain
700    1_
$a Celia, Antonio $u Department of Urology, San Bassiano Hospital, Bassano del Grappa, Italy
700    1_
$a Gontero, Paolo $u Division of Urology, Department of Surgical Sciences, University of Torino School of Medicine, Turin, Italy
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, University of Texas Southwestern Medical center, Dallas, TX; Department of Urology, Weill Cornell Medical College, New York, NY; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
700    1_
$a Trombetta, Carlo $u Urological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy
700    1_
$a Pavan, Nicola $u Urological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy
773    0_
$w MED00008671 $t Urologic oncology $x 1873-2496 $g Roč. 41, č. 1 (2023), s. 49.e13-49.e22
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36274030 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151454 $b ABA008
999    __
$a ok $b bmc $g 1891053 $s 1183383
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 41 $c 1 $d 49.e13-49.e22 $e 20221021 $i 1873-2496 $m Urologic oncology $n Urol Oncol $x MED00008671
LZP    __
$a Pubmed-20230120
Back

Find record

Citation metrics

Archiving options